Form 8-K - Current report:
SEC Accession No. 0001070081-21-000007
Filing Date
2021-02-25
Accepted
2021-02-25 16:11:39
Documents
14
Period of Report
2021-02-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ptct-20210225x8k.htm   iXBRL 8-K 45315
2 EX-99.1 ptct-20210225ex991309daf.htm EX-99.1 308453
3 GRAPHIC ptct-20210225ex991309daf001.jpg GRAPHIC 5244
  Complete submission text file 0001070081-21-000007.txt   500924

Data Files

Seq Description Document Type Size
4 EX-101.SCH ptct-20210225.xsd EX-101.SCH 3028
5 EX-101.LAB ptct-20210225_lab.xml EX-101.LAB 15410
6 EX-101.PRE ptct-20210225_pre.xml EX-101.PRE 9802
7 EXTRACTED XBRL INSTANCE DOCUMENT ptct-20210225x8k_htm.xml XML 4682
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 21680445
SIC: 2834 Pharmaceutical Preparations